DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
0.4499
-0.0001 (-0.02%)
Aug 14, 2025, 1:52 PM - Market open
DarioHealth Revenue
DarioHealth had revenue of $5.37M in the quarter ending June 30, 2025, a decrease of -14.16%. This brings the company's revenue in the last twelve months to $27.15M, up 41.79% year-over-year. In the year 2024, DarioHealth had annual revenue of $27.04M with 32.86% growth.
Revenue (ttm)
$27.15M
Revenue Growth
+41.79%
P/S Ratio
0.90
Revenue / Employee
$134,396
Employees
202
Market Cap
20.47M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 27.04M | 6.69M | 32.86% |
Dec 31, 2023 | 20.35M | -7.30M | -26.41% |
Dec 31, 2022 | 27.66M | 7.14M | 34.82% |
Dec 31, 2021 | 20.51M | 12.94M | 170.76% |
Dec 31, 2020 | 7.58M | 17.00K | 0.22% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
DRIO News
- 2 days ago - DarioHealth Corp. (DRIO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - DarioHealth Reports Second Quarter 2025 Financial and Operating Results - PRNewsWire
- 9 days ago - DarioHealth to Report Second Quarter 2025 Results on Tuesday, August 12, 2025 - PRNewsWire
- 7 weeks ago - Dario and GreenKey Health Announce Strategic Commercial Agreement to Transform Chronic Condition Management and Sleep Health for Payers Nationwide - PRNewsWire
- 7 weeks ago - Dario Unveils Groundbreaking GLP-1 and AI-Personalization Digital Health Findings - PRNewsWire
- 3 months ago - DarioHealth Corp. (DRIO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - DarioHealth Reports First Quarter 2025 Financial and Operating Results - PRNewsWire
- 3 months ago - Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations - PRNewsWire